Literature DB >> 21367923

Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney.

M-L Gross1, G Piecha, A Bierhaus, W Hanke, T Henle, P Schirmacher, E Ritz.   

Abstract

There is increasing evidence that proteins in tubular fluid are "nephrotoxic." In vivo it is difficult to study protein loading of tubular epithelial cells in isolation, i.e., without concomitant glomerular damage or changes of renal hemodynamics, etc. Recently, a unique amphibian model has been described which takes advantage of the special anatomy of the amphibian kidney in which a subset of nephrons drains the peritoneal cavity (open nephrons) so that intraperitoneal injection of protein selectively causes protein storage in and peritubular fibrosis around open but not around closed tubules. There is an ongoing debate as to what degree albumin per se is nephrotoxic and whether modification of albumin alters its nephrotoxicity. We tested the hypothesis that carbamylation and glycation render albumin more nephrotoxic compared with native albumin and alternative albumin modifications, e.g., lipid oxidation and lipid depletion. Preparations of native and modified albumin were injected into the axolotl peritoneum. The kidneys were retrieved after 10 days and studied by light microscopy as well as by immunohistochemistry [transforming growth factor (TGF)-β, PDGF, NF-κB, collagen I and IV, RAGE], nonradioactive in situ hybridization, and Western blotting. Two investigators unaware of the animal groups evaluated and scored renal histology. Compared with unmodified albumin, glycated and carbamylated albumin caused more pronounced protein storage. After no more than 10 days, selective peritubular fibrosis was seen around nephrons draining the peritoneal cavity (open nephrons), but not around closed nephrons. Additionally, more intense expression of RAGE, NF-κB, as well as PDGF, TGF-β, EGF, ET-1, and others was noted by histochemistry and confirmed by RT-PCR for fibronectin and TGF-β as well as nonradioactive in situ hybridization for TGF-β and fibronectin. The data indicate that carbamylation and glycation increase the capacity of albumin to cause tubular cell damage and peritubular fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367923     DOI: 10.1152/ajprenal.00342.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  15 in total

1.  Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus.

Authors:  Ligia Petrica; Adrian Vlad; Gheorghe Gluhovschi; Alina Zamfir; Cristina Popescu; Florica Gadalean; Victor Dumitrascu; Daliborca Vlad; Roxana Popescu; Silvia Velciov; Cristina Gluhovschi; Flaviu Bob; Oana Milas; Sorin Ursoniu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

3.  The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease.

Authors:  Gearoid M McMahon; Conall M O'Seaghdha; Shih-Jen Hwang; James B Meigs; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2013-09-19       Impact factor: 5.992

Review 4.  Avenues for post-translational protein modification prevention and therapy.

Authors:  Mengyao Tang; Sahir Kalim
Journal:  Mol Aspects Med       Date:  2022-02-25

5.  Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.

Authors:  Sahir Kalim; Hector Tamez; Julia Wenger; Elizabeth Ankers; Caitlin A Trottier; Joseph J Deferio; Anders H Berg; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

6.  Mechanism of how carbamylation reduces albumin binding to FcRn contributing to increased vascular clearance.

Authors:  Shiv Pratap S Yadav; Ruben M Sandoval; Jingfu Zhao; Yifan Huang; Exing Wang; Sudhanshu Kumar; Silvia B Campos-Bilderback; George Rhodes; Yehia Mechref; Bruce A Molitoris; Mark C Wagner
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

7.  Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.

Authors:  Sahir Kalim; Anders H Berg; Subbian Ananth Karumanchi; Ravi Thadhani; Andrew S Allegretti; Sagar Nigwekar; Sophia Zhao; Anand Srivastava; Dominic Raj; Rajat Deo; Anne Frydrych; Jing Chen; James Sondheimer; Tariq Shafi; Matthew Weir; James P Lash
Journal:  Nephrol Dial Transplant       Date:  2021-12-31       Impact factor: 7.186

8.  Receptor-mediated endocytosis of lysozyme in renal proximal tubules of the frog Rana temporaria.

Authors:  E V Seliverstova; N P Prutskova
Journal:  Eur J Histochem       Date:  2015-04-13       Impact factor: 3.188

9.  Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.

Authors:  Anders H Berg; Christiane Drechsler; Julia Wenger; Roberto Buccafusca; Tammy Hod; Sahir Kalim; Wenda Ramma; Samir M Parikh; Hanno Steen; David J Friedman; John Danziger; Christoph Wanner; Ravi Thadhani; S Ananth Karumanchi
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

Review 10.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.